Pfizer sues Poland and Hungary over Covid debts / Photo: Sylvain THOMAS - AFP/File
-
Vessel operator seeks witnesses after Vancouver grounding
-
Bezos grant helps Seattle nonprofit move thousands of families toward housing
-
Shrini Srivastava joins crew of Varanasi-Delhi Vande Bharat Sleeper service
-
US stocks fall before midterm Election Day as technology shares weaken
-
Nearly Half of Australian Workers Overqualified, Survey Finds
-
BLS Polymers makes strong market debut at ₹248 per share
-
RBI eases export-declaration compliance for individual service exporters
-
Petrol and diesel prices remain broadly steady across major Indian cities
-
Reliance shares remain in focus after near-12% surge
-
Derek Tierney Outlines Ten-Year Strategy for National Digital Health System
-
Coal India prepares possible $1 billion Mahanadi Coalfields listing
-
BLS Polymers shares open 65.3% above IPO price
-
Capital-markets shares rally as Motilal Oswal and Angel One lead gains
-
ITC shares rise as analysts anticipate gradual cigarette-business recovery
-
Reliance rally puts historical one-year return pattern in focus
-
The Digital Burden: Why Instant Messaging Feels Like a Full-Time Job
-
Saudi Aramco quarterly profit climbs 34.6% amid elevated oil prices
-
Korea’s Labor Share of GDP Hits Record Low Amid Semiconductor Boom
-
Australia raises benchmark rate to highest level in 18 years
-
littlefish and Halo Dot Partner to Replace Payment Terminals with SoftPOS
-
Asian stocks retreat as AI worries outweigh steep oil-price drop
-
Egypt Accelerates Construction of 341km Sinai Railway Linking Arish and Taba
-
Hamad International Airport stages emergency drills during WATAN 2026
-
Web Summit Qatar 2026 generated QR1 billion economic impact, report says
-
Qatar solar expansion opens scope for technical performance gains
Pfizer sues Poland and Hungary over Covid debts
Pharmaceutical firms Pfizer and BioNTech are suing the governments of Poland and Hungary alleging they failed to pay for vaccines ordered during the Covid pandemic, lawyers said Tuesday.
EU member countries ordered vaccines for their population through a joint purchase scheme, and so the companies are bringing their case before the courts in Belgium, the European Commission's host country.
According to the law firm representing Poland in the case, the US and German companies are demanding that Poland pay a debt of 5.6 billion zlotys, or 1.3 billion euros ($1.4 billion), plus interest.
Hungary is also accused of breach of contract, but a source close to the case told AFP that Budapest faces a much smaller claim of 60 million euros for three million vaccine doses.
Pfizer confirmed the cases were under way but would not confirm the sums demanded.
"Pfizer and BioNTech are seeking to recover money owed for Covid-19 vaccine orders which were contractually agreed with these governments, as part of their contract to supply the European Union signed in May 2021," the two companies said.
- 'Large quantities' -
According to Brussels law firm Strelia, Poland's dispute with Pfizer goes back to April 2022.
Then, the Polish government "informed Pfizer Inc. and the EU Commissioner for Health and Food and Safety that it will not take delivery of the vaccines, and it invoked several legal arguments and factual circumstances in support of its position".
In a social media post earlier this month, Hungarian government spokesman Zoltan Kovacs accused the European Commission and Pfizer of colluding to squeeze money out of EU member states.
"It is obvious that these vaccines were ordered and forced on member states in unnecessarily large quantities," said Kovacs, who is Prime Minister Viktor Orban's chief of international communication.
Pfizer contested these arguments and alleged breach of contract, lodging the complaint against Poland in September.
The Brussels court told AFP that an introductory hearing would be held on January 30.
No evidence has been presented of any corruption in the European Commission joint purchasing scheme.
But commission president Ursula von der Leyen has been criticised by the EU ombudsman for refusing to make her text messages with Pfizer CEO Albert Bourla part of the public record.
Ng.A.Adebayo--CPN